Hospital acquired disease testing Market to Rise at a CAGR of 14.7% during Forecast Period, notes TMR Study

𝐇𝐨𝐬𝐩𝐢𝐭𝐚𝐥-𝐚𝐜𝐪𝐮𝐢𝐫𝐞𝐝 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐭𝐞𝐬𝐭𝐢𝐧𝐠 refers to the diagnostic procedures conducted within healthcare facilities to detect infections or diseases acquired by patients during their hospital stay. These tests are crucial for identifying pathogens, such as bacteria, viruses, or fungi, responsible for nosocomial infections. Hospital-acquired diseases pose a significant risk to patient safety and can lead to complications, prolonged hospitalization, and increased healthcare costs. Therefore, prompt and accurate testing is essential for early detection, appropriate treatment, and implementation of infection control measures to prevent further spread within healthcare settings.

Hospital acquired disease testing market to reach US$ 2.85 Bn by 2027, market to expand at a CAGR of 14.7% from 2019 to 2027.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1759&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

𝐊𝐞𝐲 𝐃𝐫𝐢𝐯𝐞𝐫𝐬:

Rapid and efficient solutions for infection detection not only assist in controlling the incidence of nosocomial infections, but also in controlling the overall medical costs, hospital stays, and death.

Widespread availability of more sophisticated infection detection solutions particularly those under molecular diagnostics and their proven efficiency in delivering faster results has led to rise in demand for such products across the world.

Government initiatives and hospital acquired infection controlling authorities focusing on spreading awareness about hospital acquired infection and available treatments are driving demand for hospital acquired infection testing.
Therefore, increase in prevalence of hospital acquired infections and rise in drug resistant pathogens are fueling the growth of the hospital acquired infection testing market.

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:

Abbott Laboratories,Alere, Inc.,,Becton,Dickinson and Company,bioMérieux SA, F,Hoffmann-La Roche Ltd,Hologic, Inc, Siemens Healthcare,Diatherix Laboratories, Inc.,Meridian Bioscience, Inc.,,Thermo Fisher Scientific, Inc.

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

𝐓𝐞𝐬𝐭 𝐓𝐲𝐩𝐞

Urinary Tract
Surgical Site
Pneumonia
Bloodstream
MRSA
Others

𝐊𝐞𝐲 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬:

In January 2015, bioMérieux acquired the CEERAM (European Centre for Expertise and Research on Microbial Agents), an innovative molecular virology laboratory that specializes in the detection of foodborne and environmental viruses.

𝐏𝐥𝐚𝐜𝐞 𝐚𝐧 𝐎𝐫𝐝𝐞𝐫 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.transparencymarketresearch.com/checkout.php?rep_id=1759<ype=S&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐚𝐧𝐝 𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬:

Key drivers propelling market growth include increasing incidences of hospital-acquired infections, growing awareness regarding infection control measures, and technological advancements in diagnostic testing. However, challenges such as stringent regulatory requirements, cost constraints, and limited access to advanced healthcare facilities in certain regions may impede market expansion.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬:

Noteworthy trends in the hospital-acquired disease testing market include the adoption of rapid diagnostic tests, the integration of artificial intelligence and machine learning algorithms for data analysis, and the emergence of point-of-care testing solutions for decentralized healthcare settings.

𝐅𝐮𝐭𝐮𝐫𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:

The future outlook for the hospital-acquired disease testing market is promising, with continued advancements in testing technologies, strategic collaborations among key market players, and a growing focus on preventive healthcare driving market growth.

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲 𝐏𝐨𝐢𝐧𝐭𝐬:

Key areas of focus for market research include assessing the efficacy of diagnostic tests, evaluating market penetration strategies, analyzing regulatory landscapes, and identifying emerging trends shaping market dynamics.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐌𝐑:

𝐄𝐥𝐞𝐜𝐭𝐫𝐨𝐧𝐢𝐜 𝐇𝐞𝐚𝐥𝐭𝐡 𝐑𝐞𝐜𝐨𝐫𝐝𝐬 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/05/10/2665548/0/en/Electronic-Health-Records-Market-likely-to-surpass-USD-50-Bn-by-2031-expanding-at-a-5-CAGR-TMR-Report.html

𝐀𝐮𝐭𝐨𝐦𝐨𝐭𝐢𝐯𝐞 𝐓𝐢𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/05/10/2665446/0/en/Demand-for-Automotive-Tire-is-Expected-to-Progress-at-a-CAGR-of-4-4-to-Reach-US-209-2-Billion-by-2031-Transparency-Market-Research-Report.html

𝐀𝐛𝐨𝐮𝐭 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com        
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.